Piper Jaffray Downgrades Questcor Pharmaceuticals (QCOR) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/24/2024
- Wall Street closes higher as investors digest earnings, megacap outlook
- Tesla touts acceleration of new models, but Q1 results fall short of estimates
- JPMorgan is worried about further S&P 500 sell-off potential
- Oil rises as dollar slips, focus shifts to economic data
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Seagate Technology (STX) Enters $600M Asset Purchase Agreement with Avago
- China acquired top-end Nvidia AI chips despite recent US ban- Reuters
- Wolfe Research Downgrades Warner Brothers Discovery (WBD) to Underperform, 'out of concern that an incipient advertising downturn put guidance at risk'
- Forward Air (FWRD) Appoints Shawn Stewart as CEO
- After-hours movers: Tesla, Texas Instruments, Seagate, Visa and more
- Midday movers: PepsiCo, JetBlue fall; GM, Danaher and UPS rise
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
Questcor (QCOR) Slammed on U.S. Marketing Probe, Ratings Downgrade on Acthar Risk
September 24, 2012 7:59 AM EDTShares of Questcor Pharmacueticals, Inc. (NASDAQ: QCOR) are getting slammed in early trading Monday, down over 25 percent in pre-market action. The drop is the result of Questcor... More
U.S. Commences Probe into Questcor (QCOR) Over Marketing Practices
September 24, 2012 6:25 AM EDTOn September 21, 2012, Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR) became aware of a U.S. government investigation involving the Companys promotional practices.
The Company intends to cooperate with the government in its investigation. Company representatives will not be able to provide any additional... More
